Physician Reasons for or Against Treatment Intensification in Patients With Metastatic Prostate Cancer.

ABSTRACT:

Importance

Clarifying the underutilization of treatment intensification (TI) for metastatic castration-sensitive prostate cancer (mCSPC) may improve implementation of evidence-based medicine and survival outcomes.

Objective

To investigate physicians' beliefs about TI in mCSPC to understand the gap between evidence-based guidelines and clinical practice.

Design, setting, and participants

This survey study analyzed data from the Adelphi Real World retrospective survey, which comprised physician surveys that were linked to medical record reviews of US adult patients treated for mCSPC between July 2018 and January 2022.

Main outcomes and measures

The survey included questions on physician and practice demographics. Physicians completed patient record forms, based o

SUBMITTER: Agarwal N 

PROVIDER: S-EPMC11629128 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature